Vivo Capital’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
Vivo Capital's ADRX Position: Q3 2026 in Review
Vivo Capital opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 255,158 shares worth $5.09M. The stake represents 0.56% of the portfolio and ranks #39 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- Vivo Capital held 255,158 shares of ADARx Pharmaceuticals worth $5.09M as of Q3 2026.
- ADARx Pharmaceuticals was a new Vivo Capital position in Q3 2026.
- ADARx Pharmaceuticals made up 0.56% of Vivo Capital's portfolio in Q3 2026, its #39 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on Vivo Capital's 13F filing for Q3 2026, filed 13 Nov 2026.